Associations between metabolic factors and coronary plaque growth or arterial remodeling as assessed by intravascular ultrasound in patients with stable angina

Hypertension Research

Volumn 31, Issue 10, 2008, Pages 1879-1886

  Iwata, Atsushi ^a   Miura, Shin Ichiro ^a   Mori, Ken ^a   Kawamura, Akira ^a   Nishikawa, Hiroaki ^a   Saku, Keijiro ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; ADIPONECTIN, HUMAN; BIOLOGICAL MARKER; UNCLASSIFIED DRUG;

ADULT; ANGIOCARDIOGRAPHY; ARTERIAL REMODELING; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL PARAMETERS; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; INTERVENTIONAL RADIOLOGY; INTRAVASCULAR ULTRASOUND; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PLAQUE AREA; PLAQUE VOLUME; PROTEIN BLOOD LEVEL; REMODELING INDEX; STABLE ANGINA PECTORIS; AGED; ANGINA PECTORIS; BLOOD; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; HEART VENTRICLE REMODELING; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ADIPONECTIN; AGED; ANGINA PECTORIS; BIOLOGICAL MARKERS; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, INTERVENTIONAL; VENTRICULAR REMODELING;

EID: 58149391412     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1879     Document Type: Article

References (34)

1. Glagov S, Weisenberg E, Zarins CK, et al: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316: 1371-1375.
2. Hermiller JB, Tenaglia AN, Kisslo KB, et al: In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. Am J Cardiol 1993; 71: 665-668.
3. Losordo DW, Rosenfield K, Kaufman J, et al: Focal compensatory enlargement of human arteries in response to progressive atherosclerosis. In vivo documentation using intravascular ultrasound. Circulation 1994; 89: 2570-2577.
4. Katayama T, Kubo N, Takagi Y, et al: Relation of atherothrombosis burden and volume detected by intravascular ultrasound to angiographic no-reflow phenomenon during stent implantation in patients with acute myocardial infarction. Am J Cardiol 2006; 97: 301-304.
5. Pasterkamp G, Wensing PJ, Post MJ, et al: Paradoxical arterial wall shrinkage may contribute to luminal narrowing of human atherosclerotic femoral arteries. Circulation 1995; 91: 1444-1449.
6. Mintz GS, Kent KM, Pichard AD, et al: Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses. An intravascular ultrasound study. Circulation 1997; 95: 1791-1798.
7. Kimura T, Kaburagi S, Tamura T, et al: Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy. Circulation 1997; 96: 475-483.
8. Schoenhagen P, Ziada KM, Kapadia SR, et al: Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: An intravascular ultrasound study. Circulation 2000; 101: 598-603.
9. Koji Y, Tomiyama H, Yamada J, et al: Relationship between arterial stiffness and the risk of coronary artery disease in subjects with and without metabolic syndrome. Hypertens Res 2007; 30: 243-247.
10. Lakka HM, Laaksonen DE, Lakka TA, et al: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
11. Nakamura Y, Shimada K, Fukuda D, et al: Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 2004; 90: 528-533.
12. Otsuka F, Sugiyama S, Kojima S, et al: Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease. J Am Coll Cardiol 2006; 48: 1155-1162.
13. Gronenschild E, Janssen J, Tijdens F: CAAS. II: A second generation system for off-line and on-line quantitative coronary angiography. Cathet Cardiovasc Diagn 1994; 33: 61-75.
14. Arita Y, Kihara S, Ouchi N, et al: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83.
15. Kojima S, Funahashi T, Maruyoshi H, et al: Levels of the adipocyte-derived plasma protein, adiponectin, have a close relationship with atheroma. Thromb Res 2005; 115: 483-490.
16. Ouchi N, Kihara S, Arita Y, et al: Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473-2476.
17. Nakamura M, Nishikawa H, Mukai S, et al: Impact of coronary artery remodeling on clinical presentation of coronary artery disease: An intravascular ultrasound study. J Am Coll Cardiol 2001; 37: 63-69.
18. Ehara S, Kobayashi Y, Yoshiyama M, et al: Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: An intravascular ultrasound study. Circulation 2004; 110: 3424-3429.
19. Maehara A, Mintz GS, Bui AB, et al: Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. J Am Coll Cardiol 2002; 40: 904-910.
20. Kotani J, Mintz GS, Castagna MT, et al: Intravascular ultra-sound analysis of infarct-related and non-infarct-related arteries in patients who presented with an acute myocardial infarction. Circulation 2003; 107: 2889-2893.
21. Ouchi N, Kihara S, Arita Y, et al: Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001; 103: 1057-1063.
22. Okamoto Y, Kihara S, Ouchi N, et al: Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002; 106: 2767-2770.
23. Kumada M, Kihara S, Ouchi N, et al: Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004; 109: 2046-2049.
24. Kojima S, Funahashi T, Sakamoto T, et al: The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart 2003; 89: 667-668.
25. Folsom AR, Wu KK, Rosamond WD, et al: Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997; 96: 1102-1108.
26. Nakano Y, Tajima S, Yoshimi A, et al: A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin. J Lipid Res 2006; 47: 1572-1582.
27. Furuya R, Odamaki M, Kumagai H, et al: Impact of angiotensin II receptor blocker on plasma levels of adiponectin and advanced oxidation protein products in peritoneal dialysis patients. Blood Purif 2006; 24: 445-450.
28. Chujo D, Yagi K, Asano A, et al: Telmisartan treatment decreases visceral fat accumulation and improves serum levels of adiponectin and vascular inflammation markers in Japanese hypertensive ptients. Hypertens Res 2007; 30: 1205-1210.
29. Sacks FM, Pfeffer MA, Moye LA, et al: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335: 1001-1009.
30. Serruys PW, de Feyter P, Macaya C, et al: Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: A randomized controlled trial. JAMA 2002; 287: 3215-3222.
31. Jensen LO, Thayssen P, Pedersen KE, et al: Regression of coronary atherosclerosis by simvastatin: A serial intravascular ultrasound study. Circulation 2004; 110: 265-270.
32. Nicholls SJ, Tuzcu EM, Schoenhagen P, et al: Effect of atorvastatin (80 mg/day) versus pravastatin (40 mg/day) on arterial remodeling at coronary branch points (from the REVERSAL study). Am J Cardiol 2005; 96: 1636-1639.
33. von Birgelen C, Hartmann M, Mintz GS, et al: Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (≥12 months) follow-up intravascular ultrasound. Circulation 2003; 108: 2757-2762.
34. Iwata A, Miura S, Shirai K, et al: Lower level of low-density lipoprotein cholesterol by statin prevents progression of coronary restenosis after successful stenting in acute myocardial infarction. Intern Med 2006; 45: 885-890.